Medical Director, Clinical Development

About Aerogen Pharma:
Aerogen Pharma is a US based clinical-stage specialty pharmaceutical company with a mission to develop inhaled drug/biologic and device combination that will transform the standard of care for acute and critically ill patients. Our goal is to create medically superior, proprietary and commercially differentiated combination products by combining proven therapeutic molecules with a unique, high-performance aerosol delivery system.

We are embarking on an exciting and dynamic stage in our combination product development, moving into phase 3 clinical trial for one of the biggest breakthroughs in Neonatal care. We are a team of passionate industry experts who are leading, shaping, and driving a potentially transformative medical breakthrough for the treatment of neonatal respiratory distress syndrome (RDS) in the developed world.

Additionally, in partnership with The Bill & Melinda Gates Foundation, we have an ambitious program in development to bring low-cost surfactant to the millions of premature babies with RDS born each year.

Join us as we embark on this breakthrough and become inspired to deliver.

Thie Medical Director, under the direction of the Chief Medical Officer (CMO), provides medical and scientific leadership for Aerogen Pharma’s clinical development programs, ensuring alignment with corporate strategy and compliance with all regulatory, ethical, and scientific standards. You will execute and oversee clinical programs across the product lifecycle, including early- and late-stage development, post-marketing activities, and real-world evidence initiatives, to support business objectives and regulatory submissions.

This role works closely with stakeholders across the business to accomplish delivery of product driven initiatives, build and develop enduring peer-to-peer relationships with healthcare professionals and institutions creating constructive, cross-functional partnerships with internal and external stakeholders. In addition, preparation of scientific presentations/talks, responsibility for internal and external medical publications, and clinical sections of regulatory documents will be a key responsibility.

• Lead the medical strategy for assigned programs, including the design, execution, interpretation, and communication of clinical studies.
• Support and oversee Investigator-Initiated Research (IIR) by developing scientific concepts, evaluating proposals, ensuring appropriate governance, and maintaining compliant collaboration with investigators.
• Serve as a key medical liaison to external experts, including clinical investigators, key opinion leaders (KOLs), and healthcare institutions.
• Build and sustain credible, peer-to-peer scientific relationships that enhance Aerogen Pharma’s presence within the medical and scientific community.
• Plan, execute, and provide medical leadership for advisory boards, steering committees, and expert panels to drive high-quality scientific exchange and actionable insights.
• Partner cross-functionally with Clinical Operations, Regulatory Affairs, Pharmacovigilance, Commercial, Market Access, and R&D to deliver product-driven initiatives and ensure consistent medical messaging.
• Provide medical input into regulatory strategy and documentation, including clinical sections of INDs, NDAs/MAAs, protocols, investigator brochures, clinical study reports, and responses to health authority inquiries.
• Contribute to safety oversight activities, including review of adverse events, risk management plans, and benefit–risk assessments in collaboration with Pharmacovigilance.
• Develop and deliver scientific communications such as medical presentations, congress materials, publications, abstracts, and internal training content.
• Act as a scientific resource for internal stakeholders to ensure accurate and compliant dissemination of medical information.
• Ensure all activities comply with applicable laws, regulations, industry codes of practice, and internal policies.
• Support continuous improvement of medical processes, governance, and standards to advance the Aerogen Pharma medical function.